Group One Trading
ABVX

Group One Trading’s Abivax ABVX Stock Holding History

Group One Trading’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.9M Buy
269,200
+218,100
+427% +$24.7M 0.05% 332
2026
Q1 		$5.69M Sell
51,100
-83,600
-62% -$9.89M 0.01% 1202
2025
Q4 		$18.2M Buy
+134,700
New +$14.7M 0.03% 602

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Group One Trading's ABVX Position: Q2 2026 in Review

Group One Trading reduced its Abivax (ABVX) stake by 17% in Q2 2026, selling an estimated $679K and leaving 29,767 shares worth $3.97M. The position accounts for 0.01% of the portfolio, ranked #1607.

Group One Trading first reported a position in ABVX in Q3 2025 and has held it in 4 quarters since. The position peaked at $3.98M in Q1 2026. 303 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Group One Trading held 29,767 shares of Abivax worth $3.97M as of Q2 2026.
  • Group One Trading sold 6,000 Abivax shares in Q2 2026, an estimated $679K.
  • Abivax made up 0.01% of Group One Trading's portfolio in Q2 2026, its #1607 holding.
  • Group One Trading first reported a position in Abivax in Q3 2025 and has held it in 4 quarters since.
  • Group One Trading's Abivax position peaked at $3.98M in Q1 2026.
  • 303 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.